Journey of Vaccine Development against Ebola Virus

Authors:

Shweta*

Volume 2, Issue 6

Abstract

The 2014 outbreak of Ebola epidemic in Guinea, Liberia and Sierra Leone affected more than 28000 individuals and killed around 11300 persons. The situation exposed unpreparedness of the world towards this neglected tropical disease confined to the African continent and highlighted the need for a vaccine. This review tries to cover the excursion of EBOV vaccine development from animal models to the clinical trials and finally on-field trials during the hours of emergency.

Keywords:

View PDF